Conavi Medical Corp. CNVI.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 30.76% | 54.63% | -- | -- | -- |
| Total Depreciation and Amortization | 5.39% | -5.67% | -- | -- | -- |
| Total Amortization of Deferred Charges | -43.25% | -55.88% | -- | -- | -- |
| Total Other Non-Cash Items | -93.65% | -104.52% | -- | -- | -- |
| Change in Net Operating Assets | 144.98% | -219.51% | -- | -- | -- |
| Cash from Operations | 23.39% | -6.94% | -- | -- | -- |
| Capital Expenditure | -124.25% | 84.09% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -106.47% | -108.52% | -- | -- | -- |
| Cash from Investing | -121.44% | -110.95% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -26.91% | -42.81% | -- | -- | -- |
| Issuance of Common Stock | -45.96% | 127.36% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -118.80% | -- | -- | -- | -- |
| Cash from Financing | -70.32% | 61.45% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -207.75% | 292.15% | -- | -- | -- |